A detailed history of Man Group PLC transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Man Group PLC holds 40,549 shares of INMB stock, worth $327,230. This represents 0.0% of its overall portfolio holdings.

Number of Shares
40,549
Previous 15,654 159.03%
Holding current value
$327,230
Previous $176,000 170.45%
% of portfolio
0.0%
Previous 0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$10.53 - $14.01 $262,144 - $348,778
24,895 Added 159.03%
40,549 $476,000
Q4 2023

Feb 14, 2024

BUY
$6.6 - $11.52 $103,316 - $180,334
15,654 New
15,654 $176,000

Others Institutions Holding INMB

About Inmune Bio, Inc.


  • Ticker INMB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 17,946,000
  • Market Cap $145M
  • Description
  • INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...
More about INMB
Track This Portfolio

Track Man Group PLC Portfolio

Follow Man Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Man Group PLC with notifications on news.